In a recent study posted to the bioRxiv* pre-print server, researchers developed a highly pathogenic mouse-adapted (MA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain...
Sponsored Content by TissueGnosticsApr 26 2022Reviewed by Maria Osipova Dr. T. Diefenbach in his zoom webinar discusses the work he and his colleagues conducted at the...
In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2...
A team of UK-based scientists has recently developed a within-host model to determine the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in...
Despite evidence relating effectiveness of the current crop of vaccines used against coronavirus disease 2019 (COVID-19) in clinical trials as well as post-marketing surveillance data,...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019, ultimately causing a rapidly spreading wave of infections that affected the...
New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has identified the third...
In a recent study posted to the bioRxiv* preprint server, researchers investigated variations in the host immune response-elicited by non-structural protein 1 (nsp1) of coronaviruses...
In a recent study posted to the bioRxiv* preprint server, researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice....
The response to vaccination varies among individuals. Some vaccines cause adverse reactions, termed reactogenicity. Vaccine reactogenicity can cause physiological changes. Study: Inter-individual variation in objective...
In this interview, News-Medical speaks to Professor Jun Huang about CAR T-cell therapy and its future as a potential treatment for cancer or HIV. Please...
Checkpoint inhibitors have become important tools in the cancer-fighting arsenal. By blocking proteins that normally restrain the immune response, these drugs can help the immune...
